Browsing Centre for Cancer Prevention by Subject "multiple sclerosis"
Now showing items 1-7 of 7
-
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
(2016-09)BACKGROUND: Patient-Reported Expanded Disability Status Scale (PREDSS) tools are an attractive alternative to the Expanded Disability Status Scale (EDSS) during long term or geographically challenging studies, or in pressured ... -
Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide.
(2023-05-21)The use of high-efficacy disease-modifying therapies (DMTs) early in the course of multiple sclerosis (MS) has been shown to improve clinical outcomes and is becoming an increasingly popular treatment strategy. As a result, ... -
Multiple sclerosis - a review.
(2019-01)Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The incidence of MS is increasing worldwide, together with the socioeconomic impact of the disease. The underlying cause of ... -
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
(2022-05-12)Although there is an ever-increasing number of disease-modifying treatments for relapsing multiple sclerosis (MS), few appear to influence coronavirus disease 2019 (COVID-19) severity. There is concern about the use of ... -
UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines.
(2019-01-05)Multiple sclerosis (MS) is more common in women than men and is most commonly diagnosed in early adulthood; thus, many patients will not have completed their families at the time of diagnosis. There is increasing awareness ...